Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

NCT04443010 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Onfekafusp alfa
DRUG: Temozolomide

Sponsor

Philogen S.p.A.